FDG PET/CT findings in recurrent malignant schwannoma

Halac M., Cinaral F., Sait S., Yilmaz S., Kerim S., Sergulen D., ...More

CLINICAL NUCLEAR MEDICINE, vol.33, no.3, pp.172-174, 2008 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 3
  • Publication Date: 2008
  • Doi Number: 10.1097/rlu.0b013e318162d922
  • Journal Name: CLINICAL NUCLEAR MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.172-174
  • Istanbul University Affiliated: Yes

Abstract

Malignant schwannoma is an uncommon but aggressive sarcoma that most commonly arises in young and middle-aged adults. We present a 28-year-old male patient with a recurrent chest wall malignant schwannoma. An FDG PET/CT was performed to evaluate the management of the patient. The PET/CT images showed hypermetabolic mass lesions in the left upper chest wall and increased FDG uptake in the left axillary region. The pathologic results confirmed the PET findings. We conclude that FDG PET/CT could play an important role in the staging, restaging, and post-therapy follow-up of malignant schwannomas.